CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 59 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,268,000 | -82.1% | 1,185,124 | +2.6% | 0.14% | -82.5% |
| Q3 2018 | $7,101,000 | -37.8% | 1,154,690 | +8.0% | 0.82% | -48.3% |
| Q2 2018 | $11,425,000 | +3.4% | 1,068,720 | +3.8% | 1.58% | -6.1% |
| Q1 2018 | $11,052,000 | +250.9% | 1,030,000 | +128.9% | 1.68% | +353.5% |
| Q4 2017 | $3,150,000 | +20.1% | 450,000 | +50.0% | 0.37% | -1.1% |
| Q3 2017 | $2,622,000 | -4.1% | 300,000 | 0.0% | 0.37% | -19.4% |
| Q2 2017 | $2,733,000 | +14.7% | 300,000 | 0.0% | 0.46% | -0.4% |
| Q1 2017 | $2,382,000 | -11.2% | 300,000 | 0.0% | 0.47% | -31.4% |
| Q4 2016 | $2,682,000 | -31.6% | 300,000 | +32.7% | 0.68% | +6.3% |
| Q3 2016 | $3,923,000 | +86.5% | 226,100 | -24.6% | 0.64% | +17.0% |
| Q2 2016 | $2,103,000 | – | 300,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |